Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2025-12-24 @ 11:54 PM
NCT ID:
NCT04538651
Eligibility Criteria:
Inclusion Criteria:
* Patients with chronic hepatitis B who are older than 18 years old and younger than 75 years old;
* Currently receiving nucleotide antiviral therapy;
* Patients are willing to undergo laboratory tests related to renal function: renal function items include glomeruli Filtration rate (eGFR), urea nitrogen (BUN), blood creatinine, uric acid, beta 2 microglobulin, alpha 1 microglobulin and urine protein, etc.;
* The patient is willing to undergo blood glucose testing;
* The patients are informed and agree to participate in this session the study.
Exclusion Criteria:
* Patients with decompensated liver cirrhosis;
* Patients with HIV infection and malignant tumors;
* Patients with severe mental illness or unable to cooperate;
* Female patients during lactation and pregnancy;
* Participation within three weeks or present Those who are participating in clinical research of other new drugs;
* Those who cannot understand or express informed consent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT04538651
Study Brief:
Protocol Section:
NCT04538651